Truepill’s latest funding boosts valuation to $1.6B as it works on B2B side of healthcare
Episode 5 min 3s

Truepill’s latest funding boosts valuation to $1.6B as it works on B2B side of healthcare

The new funding represents a “hyper growth moment” for the company, which is in position to bring in some $300 million in revenue this year. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Community discussion